Open-Label Extension Study of Saroglitazar Magnesium in Participants With Primary Biliary Cholangitis
- Conditions
- Interventions
- First Posted Date
- 2024-05-23
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Zydus Therapeutics Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT06427395
- Locations
- 🇺🇸
Zydus US007, Birmingham, Alabama, United States
🇺🇸Zydus US013, Los Angeles, California, United States
🇺🇸Zydus US022, Aurora, Colorado, United States
Saroglitazar Magnesium 4 mg for Nonalcoholic Fatty Liver Disease (NAFLD) in People Living With HIV in the US
- Conditions
- Interventions
- First Posted Date
- 2022-01-27
- Last Posted Date
- 2024-12-02
- Lead Sponsor
- Zydus Therapeutics Inc.
- Target Recruit Count
- 160
- Registration Number
- NCT05211284
- Locations
- 🇺🇸
Zydus US002, Indianapolis, Indiana, United States
🇺🇸Zydus US004, Birmingham, Alabama, United States
🇺🇸Zydus US005, La Jolla, California, United States
Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis
- Conditions
- Interventions
- First Posted Date
- 2021-11-24
- Last Posted Date
- 2024-05-13
- Lead Sponsor
- Zydus Therapeutics Inc.
- Target Recruit Count
- 186
- Registration Number
- NCT05133336
- Locations
- 🇹🇷
Zydus TR010, Istanbul, Turkey
🇹🇷Zydus TR003, Istanbul, Turkey
🇹🇷Zydus TR001, Istanbul, Turkey
Hepatic Impairment With Cirrhosis Due to Cholestatic Liver Disease
- Conditions
- Interventions
- First Posted Date
- 2021-09-16
- Last Posted Date
- 2023-10-10
- Lead Sponsor
- Zydus Therapeutics Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT05045482
- Locations
- 🇺🇸
Zydus US002, Indianapolis, Indiana, United States
Saroglitazar Magnesium for the Treatment of Nonalcoholic Steatohepatitis With Fibrosis
- Conditions
- Interventions
- First Posted Date
- 2021-08-18
- Last Posted Date
- 2024-01-05
- Lead Sponsor
- Zydus Therapeutics Inc.
- Target Recruit Count
- 240
- Registration Number
- NCT05011305
- Locations
- 🇺🇸
Zydus US090, Long Beach, California, United States
🇺🇸Zydus US040, Los Angeles, California, United States
🇺🇸Zydus US059, Rancho Cucamonga, California, United States
Hepatic Impairment, Cholestatic Liver Disease, & NASH With Advanced Fibrosis & Normal Hepatic Function
- Conditions
- Interventions
- First Posted Date
- 2020-07-14
- Last Posted Date
- 2023-10-10
- Lead Sponsor
- Zydus Therapeutics Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT04469920
- Locations
- 🇺🇸
Indiana University School of Medicine, Indianapolis, Indiana, United States
🇺🇸American Research Corporation at Texas Liver Institute, San Antonio, Texas, United States
A Pharmacokinetic Study of Saroglitazar Magnesium in Subjects With Severe Renal Impairment and Normal Renal Function
- First Posted Date
- 2020-06-25
- Last Posted Date
- 2024-05-13
- Lead Sponsor
- Zydus Therapeutics Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT04446507
- Locations
- 🇺🇸
Zydus US003, DeLand, Florida, United States
🇺🇸Zydus US001, San Antonio, Texas, United States
Study to Evaluate Absorption, Metabolism and Excretion of Single-dose [14C]-Saroglitazar in Healthy Male Subjects
- First Posted Date
- 2019-10-02
- Last Posted Date
- 2019-11-13
- Lead Sponsor
- Zydus Therapeutics Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT04112446
- Locations
- 🇺🇸
Covance Clinical Research Unit Inc., Madison, Wisconsin, United States
A Study to Evaluate the Effect of Saroglitazar Magnesium on the QTc Interval in Healthy Volunteers
- Conditions
- Interventions
- First Posted Date
- 2019-08-06
- Last Posted Date
- 2020-04-21
- Lead Sponsor
- Zydus Therapeutics Inc.
- Target Recruit Count
- 52
- Registration Number
- NCT04045769
- Locations
- 🇮🇳
Cliantha Research Limited, Ahmedabad, Gujarat, India
Saroglitazar Magnesium in the Treatment of Non-Alcoholic Steatohepatitis
- Conditions
- Interventions
- First Posted Date
- 2019-03-05
- Last Posted Date
- 2024-10-11
- Lead Sponsor
- Zydus Therapeutics Inc.
- Target Recruit Count
- 16
- Registration Number
- NCT03863574
- Locations
- 🇺🇸
Texas Liver Institute, San Antonio, Texas, United States
🇺🇸Southern Therapy and Advanced Research (STAR) LLC, Jackson, Mississippi, United States
🇺🇸Gastro One, Germantown, Tennessee, United States